Skip to content

Patient having symptoms of bronchial asthma will be selected and odd even randomization will be done and add on effect of bharangiharitaki aval rha will be observed in patients and eosinophil count will be observed .

Randomised clinical trial to assess add on effect of bharangiharitaki avaleha in tamak shwasa(bronchial asthma) with special reference to eosinophil count. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074523
Enrollment
30
Registered
2024-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma Health Condition 2: J453- Mild persistent asthma Health Condition 3: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr.Namrata Shinde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having tamak shwasa symptoms like shwasakrichtta, kasa(cough) lalate sweda (sweating over forehead, asinolabhate saukhyam (comfortable in sitting position), vamathu prayaha (spitting again and again), anidra (insommnia) 2) Patient in avega avastha. 3) Patient on drug etofylline (23 mg) + theophylline (77 mg) BD 4) Sex: irrespective of sex 5) Patient of age group 18-50 will be included

Exclusion criteria

Exclusion criteria: 1) Patient with bronchiectectasis, emphysema, infective neoplasmic disease of Respiration. 2) Known case of tamak shwasa taking treatment more than 3 years. 3) Patient on drug other than etofylline (23 mg) + theophylline (77 mg) BD. 4) Patient with systemic disorder. 5) Patient in vega avasta. 6) Pregnancy, Lactating Mother.

Design outcomes

Primary

MeasureTime frame
TO STUDY ADD ON EFFECT OF BHARANGIHARITAKI AVALEHA IN TAMAKA SHWASA (BRONCHIAL ASTHMA) WITH SPECIAL REFERENCE TO EOSINOPHIL COUNTTimepoint: 30 days

Secondary

MeasureTime frame
1) To study tamak shwasa according to ayurvedicliterature. 2) To study bronchial asthma. 3) To study eosinophil count, respiratory rate, peak expiratory flow rate. 4) To study relief in tamak shwasa by using bharangiharitaki avaleha. 5) To study changes in eosinophil count, respiratory rate, peak expiratory flow rate in tamak shwasa by using bharangiharitaki avaleha.Timepoint: 12 months

Countries

India

Contacts

Public ContactDr Sandip patil

LRP Ayurvedic Medical College and Hospital

sandipkanase87@gmail.com9823531537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026